# Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects

> **NCT06043739** · PHASE1 · COMPLETED · sponsor: **Lakefront Biotherapeutics NV** · enrollment: 12 (actual)

## Conditions studied

- Bioavailability

## Interventions

- **DRUG:** Filgotinib
- **DRUG:** Filgotinib

## Key facts

- **NCT ID:** NCT06043739
- **Lead sponsor:** Lakefront Biotherapeutics NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-22
- **Primary completion:** 2023-10-27
- **Final completion:** 2023-11-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06043739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06043739, "Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT06043739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*